Pharma Aids Limited (DSE: PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT
578.60
+6.90 (1.21%)
At close: Dec 19, 2024
Pharma Aids Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 32.69 | 32.72 | 15.12 | 24.91 | 19.98 | 14.08 | Upgrade
|
Cash & Short-Term Investments | 32.69 | 32.72 | 15.12 | 24.91 | 19.98 | 14.08 | Upgrade
|
Cash Growth | 39.63% | 116.46% | -39.30% | 24.68% | 41.86% | 43.93% | Upgrade
|
Accounts Receivable | 140.75 | 129.58 | 127.1 | 123.51 | 127.23 | 136.39 | Upgrade
|
Other Receivables | 23.24 | 23.84 | 28.06 | 29.31 | 32.16 | 39.46 | Upgrade
|
Receivables | 164 | 153.43 | 155.16 | 152.82 | 159.4 | 175.85 | Upgrade
|
Inventory | 80.28 | 61.84 | 56.83 | 63.67 | 39.36 | 24.45 | Upgrade
|
Prepaid Expenses | 33.03 | 30.38 | 21.5 | 14.53 | 7.9 | 5.44 | Upgrade
|
Other Current Assets | 139.49 | 141.7 | 65.87 | 51.62 | 40.62 | 21.4 | Upgrade
|
Total Current Assets | 449.49 | 420.07 | 314.48 | 307.54 | 267.25 | 241.22 | Upgrade
|
Property, Plant & Equipment | 60.2 | 60.12 | 66.86 | 72.27 | 75.4 | 74.12 | Upgrade
|
Total Assets | 509.68 | 480.19 | 381.34 | 379.82 | 342.65 | 315.34 | Upgrade
|
Accounts Payable | 2.7 | 5.55 | 1.66 | 1.42 | 0.16 | 0.43 | Upgrade
|
Accrued Expenses | 45.66 | 38.23 | 29.72 | 32.13 | 23.69 | 23.35 | Upgrade
|
Short-Term Debt | 20.21 | 18.16 | 11.47 | 0.99 | 0.3 | 5.09 | Upgrade
|
Current Income Taxes Payable | 78.9 | 73.6 | 50.05 | 33.32 | 14.83 | 17.6 | Upgrade
|
Other Current Liabilities | 1.86 | 1.75 | 3.44 | 3.34 | 12.68 | 11.32 | Upgrade
|
Total Current Liabilities | 149.34 | 137.3 | 96.34 | 71.2 | 51.67 | 57.79 | Upgrade
|
Long-Term Deferred Tax Liabilities | -0.09 | 0.05 | 0.22 | 0.27 | - | - | Upgrade
|
Other Long-Term Liabilities | - | - | 0 | - | - | - | Upgrade
|
Total Liabilities | 149.25 | 137.35 | 96.56 | 71.47 | 51.67 | 57.79 | Upgrade
|
Common Stock | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | Upgrade
|
Retained Earnings | 327.73 | 310.42 | 253.58 | 275.56 | 257.09 | 223.43 | Upgrade
|
Comprehensive Income & Other | 1.5 | 1.23 | 0 | 1.59 | 2.69 | 2.92 | Upgrade
|
Shareholders' Equity | 360.43 | 342.85 | 284.78 | 308.35 | 290.98 | 257.56 | Upgrade
|
Total Liabilities & Equity | 509.68 | 480.19 | 381.34 | 379.82 | 342.65 | 315.34 | Upgrade
|
Total Debt | 20.21 | 18.16 | 11.47 | 0.99 | 0.3 | 5.09 | Upgrade
|
Net Cash (Debt) | 12.48 | 14.56 | 3.64 | 23.92 | 19.67 | 9 | Upgrade
|
Net Cash Growth | 245.18% | 299.67% | -84.77% | 21.59% | 118.67% | - | Upgrade
|
Net Cash Per Share | 4.00 | 4.67 | 1.17 | 7.67 | 6.31 | 2.88 | Upgrade
|
Filing Date Shares Outstanding | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade
|
Total Common Shares Outstanding | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade
|
Working Capital | 300.15 | 282.77 | 218.14 | 236.35 | 215.59 | 183.44 | Upgrade
|
Book Value Per Share | 115.52 | 109.89 | 91.28 | 98.83 | 93.26 | 82.55 | Upgrade
|
Tangible Book Value | 360.43 | 342.85 | 284.78 | 308.35 | 290.98 | 257.56 | Upgrade
|
Tangible Book Value Per Share | 115.52 | 109.89 | 91.28 | 98.83 | 93.26 | 82.55 | Upgrade
|
Land | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
Buildings | 14.29 | 14.29 | 14.29 | 14.29 | 12.57 | 12.21 | Upgrade
|
Machinery | 195 | 193.89 | 193.79 | 191.74 | 188.76 | 180.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.